๐ ๐ซ๐จ๐ฆ ๐๐๐๐ฌ ๐ญ๐จ ๐๐๐ซ๐ค๐๐ญ: ๐๐ก๐ ๐๐๐ฉ๐ข๐ ๐๐จ๐ฆ๐ฆ๐๐ซ๐๐ข๐๐ฅ๐ข๐ณ๐๐ญ๐ข๐จ๐ง ๐จ๐ ๐๐ข๐๐ซ๐จ๐ง๐๐๐๐ฅ๐๐ฌ ๐๐จ๐ซ๐ฅ๐๐ฐ๐ข๐๐
The global ๐๐ข๐๐ซ๐จ๐ง๐๐๐๐ฅ๐๐ฌ ๐๐๐ซ๐ค๐๐ญ is witnessing strong growth, driven by rising demand for minimally invasive drug delivery technologies, improved patient compliance, and expanding applications in vaccination, cosmetics, and chronic disease management. The industry is predicted to reach ๐๐๐ ๐.๐๐ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง by 2030 with a ๐๐๐๐ ๐จ๐ ๐.๐% from 2025โ2030.
๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐ ๐๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐
๐๐๐ฒ ๐๐ข๐ ๐ก๐ฅ๐ข๐ ๐ก๐ญ๐ฌ:
Growing Adoption in Healthcare โ Widely used for painless vaccine delivery and diabetes care.
Cosmetic & Dermatology Applications โ Increasing demand for anti-aging, scar reduction, and skin rejuvenation treatments.
Technological Advancements โ Emerging biodegradable microneedles and smart delivery systems.
Rising Investments โ Pharmaceutical and biotech companies are accelerating research and commercialization.
Global Demand Drivers โ Aging population, self-administration trends, and preference for less invasive treatments.
๐๐๐ฒ ๐๐ฅ๐๐ฒ๐๐ซ๐ฌ
CosMED Pharmaceutical Co., Ltd.
Nanoscribe GmbH & Co. KG
Micropoint Technologies Pte Ltd
LTS Lohmann TherapieโSysteme AG
Raphas Co., Ltd.
๐ ๐ฎ๐ญ๐ฎ๐ซ๐ ๐๐ฎ๐ญ๐ฅ๐จ๐จ๐ค
With continuous R&D and broader acceptance in both medical and cosmetic fields, microneedles are expected to revolutionize drug delivery, patient comfort, and therapeutic outcomes.















